Genetic Variations in Hyperinsulinemic Hypoglycemia: Active versus Inactive Mutations

Area of Science:

• Pediatric Endocrinology
• Medical Genetics
• Neonatology

Background:

• Hyperinsulinemic hypoglycemia (HH) is a rare neonatal condition characterized by persistent low blood glucose levels.
• This condition poses significant risks to brain development if not promptly diagnosed and managed.
• Genetic mutations affecting glucose metabolism and insulin secretion are primary causes of HH.

Purpose of the Study:

• To review the genetic variations associated with hyperinsulinemic hypoglycemia.
• To summarize current diagnostic approaches for HH.
• To outline treatment strategies for affected newborns.

Main Methods:

• Literature review of genetic mutations in 16 key genes involved in glucose metabolism and insulin secretion.
• Analysis of diagnostic methods for identifying HH.
• Summary of therapeutic interventions for managing hyperinsulinemic hypoglycemia.

Main Results:

• Identified 16 genes implicated in HH, with mutations occurring in diffuse or focal patterns affecting pancreatic beta cells.
• Highlighted the critical role of genetic variations in the pathogenesis of HH.
• Emphasized the need for accurate diagnosis to guide appropriate treatment.

Conclusions:

• Genetic mutations are the underlying cause of hyperinsulinemic hypoglycemia.
• Comprehensive genetic analysis and diagnostic evaluation are essential for effective management.
• Timely intervention is critical for improving outcomes in infants with HH.